Cero Therapeutics Holdings (CERO) Return on Assets [ROA] (2023 - 2026)
Cero Therapeutics Holdings (CERO) reported Return on Assets [ROA] of -893.19% for Q2 2026, down 666.28 percentage points from -226.92% a year earlier and down 260.05 percentage points from the prior quarter.
Powered by 
Analysis
Cero Therapeutics Holdings (CERO) Return on Assets [ROA] (2023 - 2026) Analysis & Trends
For FY2025, Cero Therapeutics Holdings posted Return on Assets [ROA] of -374.96%, down 105.33 percentage points from FY2024.
- Return on Assets [ROA] has declined for three consecutive years, with a three-year change of -374.36 percentage points (FY2022 to FY2025).
- By year, Return on Assets [ROA] came in at -269.63% in FY2024 (-258.95 pp), -10.68% in FY2023 (-10.08 pp) and -0.60% in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] in data going back to Q1 2023.
- Year over year, Return on Assets [ROA] has now declined in each of the last ten quarters, with an average year-over-year change of -254.02 percentage points over the last eight quarters.
- The year-over-year drop in Return on Assets [ROA] has ranged between 72.31 percentage points (Q1 2024) and 666.28 percentage points (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at -633.15% (Q1 2026), -488.54% (Q4 2025) and -317.77% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 2.14% |
| 10 | Cero Therapeutics Holdings | 210,875.10 | -5.27 Mn | - | -893.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -893.19% |
| Mar 31, 2026 | -633.15% |
| Dec 31, 2025 | -488.54% |
| Sep 30, 2025 | -317.77% |
| Jun 30, 2025 | -226.92% |
| Mar 31, 2025 | -233.26% |
| Dec 31, 2024 | -241.53% |
| Sep 30, 2024 | -195.80% |
| Jun 30, 2024 | -115.79% |
| Mar 31, 2024 | -81.54% |
| Dec 31, 2023 | -64.49% |
| Sep 30, 2023 | -38.65% |
| Jun 30, 2023 | -27.65% |
| Mar 31, 2023 | -9.22% |
API Access
Cero Therapeutics Holdings Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CERO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CERO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CERO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();